Number of Shares
8,700.00
Current Holdings Value*
$2.29 Mil
% of Portfolio
0.91%
Total Estimate Gain
$626,226.00
% of Total Estimate Gain
28.48%

ClearBridge Mid Cap Growth Fund's Alnylam Pharmaceuticals Inc Holding Summary

As of 2025-04-30, LEGG MASON PARTNERS EQUITY TRUST held 8,700.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $2.29 Mil. This investment constitutes 0.91% of their stock portfolio, and LEGG MASON PARTNERS EQUITY TRUST now holds 0.01% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2025Q2. And since then ClearBridge Mid Cap Growth Fund has made 1 purchases of ALNY, at an average price of $252.71, for a total of 8,700.00 shares. Based on historical transaction data and ALNY's current price of $324.69, ClearBridge Mid Cap Growth Fund's estimated gain on his ALNY holdings is $626,226.00, reflecting a 28.48% gain to date.

ClearBridge Mid Cap Growth Fund ALNY ($324.69) Holding Chart

ClearBridge Mid Cap Growth Fund ALNY ($324.69) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1